Related references
Note: Only part of the references are listed.Validation and clinical application of transactivation assays for RUNX1 variant classification
Melanie Decker et al.
BLOOD ADVANCES (2022)
Multiparametric and accurate functional analysis of genetic sequence variants using CRISPR-Select
Yiyuan Niu et al.
NATURE GENETICS (2022)
RUNX1 germline variants in RUNX1-mutant AML: how frequent?
Martijn P. T. Ernst et al.
BLOOD (2021)
Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies
Melanie Decker et al.
LEUKEMIA (2021)
Searching for germline mutations in the RUNX1 gene among Polish patients with acute myeloid leukemia
Aneta Bak et al.
LEUKEMIA & LYMPHOMA (2021)
High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML
Laura Simon et al.
BLOOD (2020)
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
Ana Rio-Machin et al.
NATURE COMMUNICATIONS (2020)
Tracy: basecalling, alignment, assembly and deconvolution of sanger chromatogram trace files
Tobias Rausch et al.
BMC GENOMICS (2020)
Runx1 negatively regulates inflammatory cytokine production by neutrophils in response to Toll-like receptor signaling
Dana C. Bellissimo et al.
BLOOD ADVANCES (2020)
RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
Rabindranath Bera et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
Xi Luo et al.
BLOOD ADVANCES (2019)
ClinVar: improving access to variant interpretations and supporting evidence
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2018)
Germline alterations in a consecutive series of acute myeloid leukemia
Ulla Wartiovaara-Kautto et al.
LEUKEMIA (2018)
Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis
Lisha Ai et al.
BMC CANCER (2018)
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies
Michael W. Drazer et al.
BLOOD ADVANCES (2018)
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
R. C. Lindsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation
Olga N. Kuvardina et al.
BLOOD (2015)
Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells
Xiongwei Cai et al.
CELL STEM CELL (2015)
Engineering T cells for cancer: our synthetic future
Robert H. Vonderheide et al.
IMMUNOLOGICAL REVIEWS (2014)
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T. Haferlach et al.
LEUKEMIA (2014)
Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients
M. Sakurai et al.
LEUKEMIA (2014)
Runt-related Transcription Factor 1 (RUNX1) Stimulates Tumor Suppressor p53 Protein in Response to DNA Damage through Complex Formation and Acetylation
Dan Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization
Larissa Lordier et al.
NATURE COMMUNICATIONS (2012)
SNVer: a statistical tool for variant calling in analysis of pooled or individual next-generation sequencing data
Zhi Wei et al.
NUCLEIC ACIDS RESEARCH (2011)
Clinical phenotype of germline RUNX1 haploinsufficiency:: from point mutations to large genomic deletions
Mylene Beri-Dexheimer et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Share Paper
